🔎 Trials Near Me

Home › Lupus › Texas › Houston

Pag-aaral pangklinika para sa Lupus sa Houston, TX

Isang pag-aaral para sa Lupus ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Nagre-recruitPhase 3
  • Research Site, Houston
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05835310

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Nagre-recruitPhase 3
  • Research Site, Houston
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07430306

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Nagre-recruitPhase 1
  • UT MD Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Nagre-recruitPhase 2
  • The University of Texas Health Science Center at Houston, Houston
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07409181

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Nagre-recruitPhase 1
  • Baylor College of Medicine, Houston
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT06975787

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Nagre-recruitPhase 3
  • Accurate Clinical Research, Humble · 17 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07355218

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Nagre-recruitPhase 3
  • Sl0044 50688, Houston
  • Sl0044 50696, Houston
  • Sl0044 50723, Houston
  • at 1 pa
Edad 16 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06617325

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Nagre-recruitPhase 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06121297

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

Nagre-recruitPhase 2
  • Prolato Clinical Research Center, Houston
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT05268289

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Nagre-recruitPhase 3
  • Novel Research, LLC., Houston
  • Northwest Houston Arthritis, Houston
  • Rheumatology Care Center, PLLC, Bellaire · 7 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07201129

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Nagre-recruitObservasyonal na pag-aaral
  • M D Anderson Cancer Center, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT04751396

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

Nagre-recruitPhase 1/2
  • MD Anderson Cancer Center, Houston
  • The University of Texas Health Science Center at Houston, Houston
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT06434363

Pag-aaral para sa Lupus sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.